RDR 02308
RDR 02308 is a TLR4-MyD88 binding inhibitor that inhibits full-length β-lactamase[1].
Product Specifications
CAS Number
4155-82-2
UNSPSC
12352005
Target
Bacterial; Beta-lactamase; Toll-like Receptor (TLR)
Type
Reference compound
Related Pathways
Anti-infection; Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/rdr-02308.html
Purity
98.0
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=[N+](C1=CC=C(C2=NN(C3=CC=CC=C3)C(C4=CC=CO4)C2)C=C1)[O-]
Molecular Formula
C19H15N3O3
Molecular Weight
333.34
References & Citations
[1]Lee HK, et al. Application of beta-lactamase enzyme complementation to the high-throughput screening of toll-like receptor signaling inhibitors. Mol Pharmacol. 2007 Oct;72 (4) :868-75.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY424705 100 µg
LKB1 (STK11) (NM_000455) Human Over-expression Lysate
Sign In for Pricing
View Details 
